logo

For the Inventor, By the Inventor

Iowa City, IA, United States of America

Charles F Barfknecht

USPTO Granted Patents = 24

Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 217(Granted Patents)


Company Filing History:

goldMedal24 out of 906 
 
University of Iowa Research Foundation
 patents

Years Active: 1976-1999

Loading Chart...
24 patents (USPTO):Explore Patents
1. 5961987 - Ocular protein stimulants (1999-10-05),
2. 5776482 - Tetrahydroquinoline analogues for use in glaucoma treatment (1998-07-07),
3. 5654335 - Topical use of ethyl ethacrynate for glaucoma treatment (1997-08-05),
4. 5565434 - Hexose and pentose prodrugs of ethacrynic acid (1996-10-15),
5. 5387614 - Use of sigma receptor ligands as salivary gland stimulants (1995-02-07),
6. 5382576 - 1-aza-1-arylcycloalkanes as topical glaucoma treatment agents (1995-01-17),
7. 5322859 - Antiglaucoma drug composition and method (1994-06-21),
8. 5256698 - Treatment of psychosis using cyclohexyl-phenyl-lower alkyl amine (1993-10-26),
9. 5225424 - Methazolamide-derived carbonic anhydrase inhibitors (1993-07-06),
10. 5179124 - Anti-inflammatory for use in external and internal eye inflammations (1993-01-12),
11. 5157044 - Analogs of carbonic anhydrase inhibitors and their use as topical IOP (1992-10-20),
12. 5104887 - Topical ophthalmic imino substituted (1992-04-14),
13. 5095026 - Prodrugs of carbonic anhydrase inhibitors (1992-03-10),
14. 4975449 - Topical treatment of glaucoma with 2-benzothiazolesulfonamide derivative (1990-12-04),
15. 4975448 - 6-amino-2-benzothiazolesulfonamide and topical treatment compositions (1990-12-04),

Title: Innovating Eye Care: The Contributions of Charles F Barfknecht

Introduction: Charles F Barfknecht is a prominent inventor based in Iowa City, IA, known for his significant contributions to the field of ocular medicine. With an impressive portfolio of 24 patents, Barfknecht has made substantial advancements in treatments for eye-related conditions.

Latest Patents: Among his latest inventions, Barfknecht has developed two notable patents. The first is an innovation focused on ocular protein stimulants, specifically tear production stimulants that are characterized by reduced basicity and prepared from cyclopropyl adducts of tertiary amines. This invention addresses the important issue of dry eye conditions, providing a new approach to enhancing tear production. His second recent patent involves tetrahydroquinoline analogues designed for glaucoma treatment. These compositions aim to effectively reduce intraocular eye pressure, offering a promising option for managing glaucoma.

Career Highlights: Barfknecht's career is marked by his role at the University of Iowa Research Foundation, where he has had the opportunity to collaborate with some of the brightest minds in the field. His innovations have not only contributed to the scientific community but have the potential to impact countless lives affected by ocular diseases.

Collaborations: Throughout his career, Charles F Barfknecht has worked alongside esteemed colleagues such as Ronald D Schoenwald and Jeffrey A Coffman. This collaborative spirit is a testament to the collective effort required in advancing scientific discoveries and developing effective treatments.

Conclusion: Charles F Barfknecht's work illustrates the vital role of innovation in medical science. Through his patents and collaborations, he continues to push the boundaries of what is possible in eye care, making strides that benefit both research and patient outcomes. His contributions stand as a beacon for aspiring inventors in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…